MedTrace Logo

Prizvalve Transcatheter Aortic Valve in Failing Bioprosthetic Valves

NCT07122050 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-08-14

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and effectiveness of the Prizvalve transcatheter aortic valve in subjects who are at high or greater risk with failing bioprosthetic valves.

Conditions

  • Failing Bioprosthetic Valves

Interventions

DEVICE

Prizvalve® system Transcatheter valve-in-valve replacement

Transcatheter valve-in-valve replacement procedure was performed according to standard clinical practice. Successful vascular access, delivery and deployment of the device and successful retrieval of the delivery system will be attempted.

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Jian Yang, MD, PhD · Department of Cardiovascular Surgery of Xijing Hospital, Air Force Military Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-15
Primary Completion
2029-09-30
Completion
2029-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07122050 on ClinicalTrials.gov